Akèy › Myelom Miltip › New York › New Rochelle
Etid klinik pou Myelom Miltip nan New Rochelle, NY
14 etid pou Myelom Miltip ap chèche patisipan nan sit nan ak bò kote New Rochelle (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Ap rekriteFaz 3
- MSK Westchester, Harrison · 5 mi lwen
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi lwen
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Ap rekriteFaz 3
- North Shore University Hospital, Manhasset · 9 mi lwen
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Ap rekriteFaz 3
- MSK Westchester, Harrison · 5 mi lwen
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Ap rekriteFaz 1
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Ap rekriteEtid obsèvasyon
- Memorial Sloan Kettering Westchester (Consent only), Harrison · 5 mi lwen
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Ap rekriteFaz 1/2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi lwen
A Dietary Study for People With Multiple Myeloma
Ap rekrite
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Ap rekriteFaz 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison · 5 mi lwen
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Memorial Sloan Kettering Westchester, Harrison · 5 mi lwen
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Ap rekrite
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · 5 mi lwen
Etid Myelom Miltip nan lòt vil
- New York City, NY60 etid
- Boston, MA42 etid
- Atlanta, GA41 etid
- Houston, TX38 etid
- Durham, NC37 etid
- Nashville, TN32 etid
- Denver, CO27 etid
- Rochester, MN24 etid
- St. Louis, MO24 etid
- Columbus, OH24 etid
- Baldwin Park, CA23 etid
- Chicago, IL22 etid
Lòt etid nan New Rochelle
- Kansè nan tete38 etid
- Kansè Poumon ki pa ti selil18 etid
- Kansè pwostat16 etid
- Leksemi mieloïd egi13 etid
- Kansè poumon11 etid
- Kansè vejik11 etid
- Kansè Endomèt11 etid
- Kansè (tout kalite)10 etid
- Kansè Metastatik10 etid
- Kansè pankreyas8 etid
- Kansè ovè8 etid
- Maladi kadyovaskilè8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.